ODAIA wins $25m funding to boost commercial insights platform for pharma
ODAIA, a life sciences predictive analytics and commercial insights provider, has secured an investment of $25m in its Series B…
ODAIA, a life sciences predictive analytics and commercial insights provider, has secured an investment of $25m in its Series B…
Verismo Therapeutics has received fast track designation from the US Food and Drug Administration (FDA) for its investigational new drug,…